Additionally, Lenart-Lipińska et al. provided evidence of increased FGF21 levels in patients suffering from ischemic coronary heart disease, chronic kidney disease and in those with a detrimental lipid profile [46]. Here, FGF21 is linked to chronic kidney disease.